Context-specific reversal of cocaine sensitization by the CB1 cannabinoid receptor antagonist rimonabant

Gregory L. Gerdeman, Jason B. Schechter, Edward D. French

Research output: Contribution to journalArticlepeer-review

41 Scopus citations

Abstract

The CB1 cannabinoid receptor is implicated in the rewarding properties of many drugs of abuse, including cocaine. While CB1 receptor involvement in the acute rewarding properties of cocaine is controversial, CB1 antagonists such as SR141716 (rimonabant) have clearly been found to prevent cue- and cocaine-elicited reinstatement of cocaine self-administration in rodents. Here we demonstrate the novel involvement of CB1 receptors in the maintenance of behavioral sensitization to cocaine in C57BL/6 mice. Consistent with previous reports, the induction of locomotor sensitization following repeated daily cocaine was not prevented by systemic pretreatment of either rimonabant, Δ9- tetrahydrocannabinol (THC), or a 1:1 mixture of THC and cannabidiol (CBD). In contrast, established cocaine sensitization was markedly disrupted following subchronic treatment with rimonabant alone. This effect was notably context-dependent, in that rimonabant did not diminish established cocaine sensitization if delivered in the home cage, but only if the rimonabant-injected mice were exposed to activity chambers previously paired with cocaine. These findings are consistent with CB1 receptor involvement in conditioned cocaine-seeking behaviors, and further suggest that endocannabinoid (eCB)-mediated synaptic plasticity may act specifically within drug-paired environments to maintain cocaine-directed behavioral responses.

Original languageEnglish (US)
Pages (from-to)2747-2759
Number of pages13
JournalNeuropsychopharmacology
Volume33
Issue number11
DOIs
StatePublished - Oct 2008

Keywords

  • Behavioral sensitization
  • Cannabinoid
  • Cocaine
  • Endocannabinoid
  • Reward
  • Rimonabant

ASJC Scopus subject areas

  • Pharmacology
  • Psychiatry and Mental health

Fingerprint

Dive into the research topics of 'Context-specific reversal of cocaine sensitization by the CB<sub>1</sub> cannabinoid receptor antagonist rimonabant'. Together they form a unique fingerprint.

Cite this